Clinical Trial Update: ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ZK-Epo in combination with prednisone for metastatic androgen-independent prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ZK-Epo (unknown)

Snippet

Sponsor: Bayer | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED